Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.
1 report, 1 independent
Updated Aug 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Novavax
company in Gaithersburg, Maryland
Nothing else this week.
-
Bank of America
American multinational banking and financial services corporation
Related events
Coverage
Newest first; wire copies grouped- Investing.comBofA downgrades Novavax stock on vaccine uncertainty Investing.com -- Bank of America cut its rating on Novavax (NASDAQ:NVAX) to Underperform from Neutral and lowered its price objective to $7 from $